Stock Analysis of Vivani Medical Inc. (VANI)

Loading ...

Birds's Eye

Technical Analysis of Vivani Medical Inc.

Stock Analysis of Vivani Medical Inc. (VANI) - Birds Eye View

1W 2W 1M 3M 1Y 2Y 5Y

Overview

Code	VANI
Close	1.63
Change	-0.0100 / 0.610 %
Volume	54079.00
Vol Change	16842.00 / 45.23 %
Industry	Medical Devices
Sector	Healthcare

AIO Strength Index

Technical Strength	Neutral
Growth Index	Very Low Growth Stock
Value Index	Poor Value Stock
Profitability Index	Poor Profitability Stock
Stability Index	Low Stability Stock

Fundamental View of Vivani Medical Inc.

PE (TTM)

-3.29

Very Poor

Price / Book

2.85

Poor

Price / Sales

161.16

Very Poor

Piotroski F Score

1.0

Very Poor

Market Cap

89614.96 K

Enterprise Value

70343.96 K

All Financial Ratio's

ROA (TTM)

-49.35

Very Poor

ROE (TTM)

-86.63

Very Poor

Net Margin (TTM)

-4898.26

Very Poor

Revenue

%

Net Profit

93.75 %

-26910.00 K

Debt to Equity

0.067

Excellent

Altman Z Score

-2.35

Very Poor

Quick Ratio

0

Poor

Cash Ratio

3.61

Very Good

Financial Statement Analysis

Highs/Lows of Vivani Medical Inc.

Period	Old price	Stock Return	S&P 500 Returns	High	Low	High Date	Low Date
One Week	1.67	2.40 %	0.513 %	1.67	1.55	30-May-24	28-May-24
Two Week	1.995	18.30 %	0.486 %	2.01	1.55	20-May-24	28-May-24
One Month	1.62	0.617 %	4.80 %	2.01	1.55	20-May-24	28-May-24
Three Month	4.22	61.37 %	3.56 %	3.47	1.55	01-Mar-24	28-May-24
Six Months	0.95	71.58 %	15.54 %	7.8	0.84	28-Feb-24	21-Dec-23
One year	1.31	24.43 %	26.26 %	7.8	0.84	28-Feb-24	21-Dec-23
Two year	21.15	92.29 %	27.72 %	7.8	0.754	28-Feb-24	06-Apr-23
Five year	429.12	99.62 %	91.77 %	17.19	0.754	18-Aug-22	06-Apr-23

Technical View of Vivani Medical Inc.

RSI

40.06

Neutral

MACD

-0.0454

Bearish

ADX

17.38

Bearish

Super Trend

1.92

Strong Bearish

Williams %R

-82.61

Mild Bullish

CCI

-103.82

Mild Bullish

Technical Analysis Deep Dive

EMA 5

1.66

Mild Bearish

EMA 15

1.72

Mild Bearish

EMA 50

1.76

Bearish

EMA 100

1.65

Whipsaw

SMA 100

1.65

Bearish

SMA 200

1.32

Bullish

SMA 5 / 20

1.65 / 1.77

Bearish

SMA 15 / 50

1.77 / 1.83

Mild Bearish

SMA 50 / 200

1.83 / 1.32

Strong Bullish

MA Analysis Deep Dive

Charts of Vivani Medical Inc.

Returns of Vivani Medical Inc. with Peers

Period / Stock	VANI	BWAY	FONR	SRTS	RLMD
1 Week	-2.40%	16.48%	1.63%	-11.15%	-1.64%
1 Mth	0.617%	19.81%	-0.953%	44.15%	-17.58%
3 Mth	-61.37%	-2.93%	-30.00%	32.20%	-51.02%
6mth	71.58%	0.319%	-18.08%	123.97%	21.46%
1 Year	24.43%	258.40%	-8.94%	101.49%	5.63%
2 Year	-92.29%	-12.03%	-3.29%	-37.49%	-84.03%
5 Years	-99.62%	-38.75%	-18.80%	-3.04%	-70.00%
charts	-

View All Together in Chart Inline Tile

Compare Fundamentals of Vivani Medical Inc. with Peers

Ratio / Stock	VANI	BWAY	FONR	SRTS	RLMD
PE	-3.29	-78.49	4.96	19.00	-0.958
P/B	2.85	2.94	2.31	1.87	0.912
ROA	-49.35	-2.68	18.93	8.72	-85.93
ROE	-86.63	-3.96	42.65	9.82	-95.26
Debt To Equity	0.067	0.0056	-0.087	0.0038	0
Revenue	0 %	28789.00 K 5.93 %	98645.10 K 1.08 %	24405.00 K 45.20 %	0 %
Net Income	-26910.00 K 93.75 %	-8191.00 K 38.64 %	19390.66 K 55.86 %	485000 98.00 %	-111570.95 K 28.96 %

Technicals of Vivani Medical Inc. with Peers

Technical / Stock	VANI	BWAY	FONR	SRTS	RLMD	-
ADX	17.38	15.00	37.02	43.69	39.53
CMF	0.252	-0.145	-0.081	0.458	-0.298
MFI	32.70	63.94	36.22	63.27	19.69
RSI	40.06	64.27	43.49	55.62	29.97
MACD Abv Signal	False	True	True	False	False
Price Above 50 MA	False	True	False	True	False	-
Price Above 200 MA	True	True	False	True	False	-

About : Vivani Medical Inc.

Address : 5858 Horton Street, EmeryVille, CA, United States, 94608
Tel : 818 833 5000
URL : https://www.vivani.com
Code : VANI, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_Nov_2014
Employee Count : 36

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Note : All Data Generated at the End of Trading Hours (EOD Data)